CAPSTONE NATIONAL PARTNERS

Lobbying for ATTERX BIOTHERAPEUTICS · Biotherapeutical development

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Wisconsin · House · Senate · $15,000.00 income · posted Oct 6, 2025

Lobbying activity 1

Medical/Disease Research/Clinical Labs

FY26 Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem